Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression

NCT00093847 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Depression

Interventions

DRUG: S-adenosyl methione (SAMe)
DRUG: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]